Article
Which biomarkers are effective for identifying Th2-driven inflammation in asthma?
Current allergy and asthma reports - 1 Oct 2013
Diamant Zuzana, Tufvesson Ellen, Bjermer Leif
Abstract excerpt
Recognition of asthma as a heterogeneous disease revealed different potential molecular targets and urged the development of targeted, customized treatment modalities. Evidence was provided for different inflammatory subsets of asthma and more recently, further refined to T helper (Th)2-high and Th2-low subphenotypes with different responsiveness to standard and targeted pharmacotherapy. Given these differences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
